(19)
(11) EP 4 816 537 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24895222.8

(22) Date of filing: 28.11.2024
(51) International Patent Classification (IPC): 
C12N 15/113(2010.01)
A61P 25/18(2006.01)
 A61P 25/00(2006.01)
(52) Cooperative Patent Classification (CPC):
C12N 15/113; C12N 2310/11; C12N 2310/3231; C12N 2310/332
 
C-Sets:
C12N 2310/321, C12N 2310/3525;
(86) International application number:
PCT/AU2024/051273
(87) International publication number:
WO 2025/111653 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 29.11.2023 AU 2023903841
29.11.2023 AU 2023903842
04.12.2023 AU 2023903916
05.12.2023 AU 2023903924
05.12.2023 AU 2023903927
06.06.2024 AU 2024901708
17.07.2024 AU 2024902223
13.11.2024 AU 2024903714

(71) Applicant: PYC THERAPEUTICS LIMITED
Nedlands, WA 6009 (AU)

(72) Inventors:
  • STIRNWEISS, Anja
    Nedlands, Western Australia 6009 (AU)
  • LANDIN, Dulce Vargas
    Nedlands, Western Australia 6009 (AU)
  • NICHOLS, Jessica
    Nedlands, Western Australia 6009 (AU)
  • GRAINOK, Janya
    Nedlands, Western Australia 6009 (AU)
  • MARTIN, Adam
    Nedlands, Western Australia 6009 (AU)

(74) Representative: Leonard, Thomas Charles et al
Kilburn & Strode LLP Lacon London 84 Theobalds Road
London WC1X 8NL
London WC1X 8NL (GB)

   


(54) IMPROVED COMPOSITIONS AND METHODS FOR TREATMENT OF MONOGENIC NEURODEVELOPMENTAL DISORDERS